• Ertapenem sodium, EvoPure packaged and labeled.

click on thumbnail to zoom
SKU: E008

Size  
Quantity:
  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Description

Ertapenem sodium, EvoPure® is a highly purified form of Ertapenem sodium.  It is a broad-spectrum β-lactam carbapenem that interferes with peptidoglycan synthesis.  Ertapenem sodium is soluble in water and sodium chloride.

    CAS Number

    153773-82-1

    Molecular Formula

    C22H24N3O7S • xNa (lot specific)

    Molecular Weight

    474.51 g/mol (Free base)

    Mechanism of Action

    β-lactams interfere with PBP (penicillin binding protein) activity involved in the final phase of peptidoglycan synthesis. PBP’s are enzymes which catalyze a pentaglycine crosslink between alanine and lysine residues providing additional strength to the cell wall. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised and ultimately leads to cell lysis and death. Resistance to β-lactams is commonly due to cells containing plasmid encoded β-lactamases.

    Storage Conditions

    -20°C

    Tariff Code

    2941.90.3000

    Spectrum

    Ertapenem sodium has broad-spectrum activity targeting a wide spectrum of aerobic and anaerobic Gram-positive and Gram-negative bacteria.

Applications

    Microbiology Applications

    Ertapenem sodium is commonly used in clinical in vitromicrobiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against gram positive microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options for infected patients. Representative MIC values include:

    • Staphylococcus aureus 0.12 µg/mL – >16 µg/mL
    • Escherichia coli ≤ 0.008 - 0.5 µg/mL

    For a complete list of ertapenem MIC values, click here.

    It is active against cephalosporin-resistant enteric organisms producing extended spectrum beta-lactamases (ESBLs) and penicillin-resistant Streptococcus pneumoniae.  It has restricted activity against nosocomial pathogens including Pseudomonas aeruginosa, Acinetobacter species, methicillin-resistant staphylococci and enterococci. 

Specifications

    Appearance

    White or light yellow powder

    Source

    synthetic

Technical Data

HPLC, NMR, FTIR, and MS analysis may be available. For more info, please email [email protected].

References

    References

    Cunha BA (2002)  Ertapenem.  A review of its microbiologic, pharmacokinetic and clinical aspects. Drugs Toay (Barc) 38(3):195-213  PMID 12532175

    Hammond ML (2004)  Ertapenem: A group 1 carbapenem with distinct antibacterial and pharmacological properties. J. Antimcrob. Chemother 53(2):7-9

    Pitout JD, Sanders CC, Sanders WE (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103:51

Other Items In This Category